Filip Lemière Selected Research

Neoplasms (Cancer)

3/2020	Preclinical Evaluation of a Novel 18F-Labeled dTCO-Amide Derivative for Bioorthogonal Pretargeted Positron Emission Tomography Imaging.
3/2019	Non-Thermal Plasma as a Unique Delivery System of Short-Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells.
4/2013	Analysis of novel melphalan hydrolysis products formed under isolated lung perfusion conditions using liquid chromatography/tandem mass spectrometry.
1/2006	Analysis of urinary nucleosides. V. Identification of urinary pyrimidine nucleosides by liquid chromatography/electrospray mass spectrometry.
1/2005	Implications of enzymatic, acidic and thermal hydrolysis of DNA on the occurrence of cross-linked melphalan DNA adducts.
1/2004	Implementation of data-dependent acquisitions in the study of melphalan DNA adducts by miniaturized liquid chromatography coupled to electrospray tandem mass spectrometry.
1/2004	Analysis of urinary nucleosides. IV. Identification of urinary purine nucleosides by liquid chromatography/electrospray mass spectrometry.
2/2003	Alkylation of DNA by melphalan: investigation of capillary liquid chromatography-electrospray ionization tandem mass spectrometry in the study of the adducts at the nucleoside level.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Filip Lemière Research Topics

Disease

8	Neoplasms (Cancer) 03/2020 - 02/2003
2	Melanoma (Melanoma, Malignant) 03/2019 - 04/2013
2	Breast Neoplasms (Breast Cancer) 03/2016 - 04/2013
1	Parkinson Disease (Parkinson's Disease) 10/2020
1	Colorectal Neoplasms (Colorectal Cancer) 03/2020
1	Sarcoma (Soft Tissue Sarcoma) 03/2016
1	Ovarian Neoplasms (Ovarian Cancer) 03/2016
1	Multiple Myeloma 04/2013
1	Ganglion Cysts (Ganglion) 08/2011
1	Communicable Diseases (Infectious Diseases) 07/2011
1	Malaria 07/2011

Drug/Important Bio-Agent (IBA)

3	Melphalan (Alkeran)FDA LinkGeneric 03/2016 - 01/2005
2	NitrogenIBA 03/2019 - 02/2003
2	NucleosidesIBA 01/2006 - 01/2004
2	DNA (Deoxyribonucleic Acid)IBA 01/2005 - 01/2004
1	SynucleinsIBA 10/2020
1	Intrinsically Disordered ProteinsIBA 10/2020
1	Monoclonal AntibodiesIBA 03/2020
1	CyclooctanesIBA 03/2020
1	Radioisotopes (Radionuclides)IBA 03/2020
1	micaIBA 03/2020
1	Plasma GasesIBA 03/2019
1	Hydroxyl RadicalIBA 03/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2019
1	Oxygen (Dioxygen)IBA 03/2019
1	Phenylalanine (L-Phenylalanine)FDA Link 04/2013
1	Cytotoxins (Cytolysins)IBA 04/2013
1	Serotonin (5 Hydroxytryptamine)IBA 08/2011
1	Plant ExtractsIBA 07/2011
1	CytidineIBA 01/2006
1	PseudouridineIBA 01/2006
1	Pyrimidine NucleosidesIBA 01/2006
1	RNA (Ribonucleic Acid)IBA 01/2006
1	N-acetylcytidineIBA 01/2006
1	XenobioticsIBA 01/2004
1	Adenosine (Adenocard)FDA LinkGeneric 01/2004
1	DNA AdductsIBA 01/2004
1	Inosine FDA Link 01/2004
1	xanthosineIBA 01/2004
1	1-methylinosineIBA 01/2004
1	N(2),N(2)-dimethylguanosineIBA 01/2004
1	1-methyladenosineIBA 01/2004

Therapy/Procedure

1	Immunotherapy 03/2019
1	Therapeutics 03/2019